Aker BioMarine, which harvests Antarctic krill for use in animal and human food, has pledged $1 million to support the Antarctic Wildlife Research Fund (AWR) over the next five years. The grant, which is on top of almost $1.5m already donated by the company since 2015, will further AWR’s work on promoting and facilitating research on the Antarctic ecosystem.

Krill harvester Aker BioMarine has received approval from the United States Food and Drug Administration (FDA) for the use of its QRILL Aqua and QRILL High Protein (QHP) products in freshwater and marine salmonids.